Table 3.
CSF examination of neuro-COVID group.
| Patient | Appearance | Protein mg/dL [15–45] |
Glucose mg/dL [50–80] |
Albumin mg/dL [0–35] |
Lactic Acid mmol/L [1.1–2.4] |
Cell Count/μL [<10] |
QAlb [0–9] | Real-Time RT-PCR in CSF (Ct Values) |
Real-Time RT-PCR in Plasma | ddPCR in CSF (RdRp cp/mL) | ddPCR in Plasma (RdRp cp/mL) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | clear | 28 | 80 | 8.2 | 1.1 | 2 | 3.3 | negative | negative | negative | negative |
| 2 | clear | 34 | 104 | 9.1 | 2.1 | 1 | 4.3 | negative | negative | negative | negative |
| 3 | clear | 17.2 | 76 | 9.3 | 1.4 | 1 | 2.6 | negative | negative | positive (11.0) | negative |
| 4 | clear | 18.2 | 89 | 8.9 | 1.6 | 1 | 3.1 | negative | negative | negative | negative |
| 5 | clear | 28.9 | 98 | 8.3 | 3.2 | 2 | 2.5 | negative | negative | negative | negative |
| 6 | clear | 37.0 | 64 | 9.1 | 3.4 | 5 | 4.0 | negative | negative | negative | negative |
| 7 | clear | 19.6 | 61 | 10.5 | 3.3 | 16 | 3.6 | negative | negative | positive (8.1) | negative |
| 8 | clear | 39.6 | 56 | 20.9 | 3.3 | 3 | 6.1 | negative | negative | negative | positive (2.0) |
| 9 | clear | 55.8 | 101 | 35.9 | 3.4 | 4 | 9.4 | negative | negative | positive (2.0) | negative |
| 10 | clear | 29.4 | 151 | 17.9 | 3.1 | 5 | 5.0 | negative | negative | negative | negative |
| 11 | clear | 25.0 | 71 | 10.0 | 2.3 | 1 | 4.3 | negative | negative | negative | positive (14.0) |
| 12 | clear | 47.0 | 86 | 29.9 | 1.8 | 5 | 7.4 | positive (34.3) | negative | positive (14.0) | negative |
QAlb: CSF/serum albumin quotient; RT-PCR: reverse transcription-polymerase chain reaction; Ct: cycle threshold, ddPCR: droplet digital polymerase chain reaction; RdRp: RNA-dependent RNA polymerase; cp: copy.